New Head of Bayer’s Consumer Health Division Impressed by NZ

New Consumer Health head impressed with NZ: NZ trade
environment more advanced and dynamic

·
Industry more liberal and innovative

· Test market
for world

· Investment to
continue

Auckland 25 September 2017
New Zealand’s OTC (over the counter) medications
environment is one of the most advanced in the world and a
model that many countries will emulate in future.

That’s
the view of Matthias Stuchly, who has just taken over as
general manager at Bayer New Zealand’s Consumer Health
division.

With more than 10 years’ experience in the OTC
industry, Stuchly has recently arrived in Auckland from
Basel, Switzerland, where he was the worldwide brand leader
for the Canesten Women’s Intimate Health range.

“New
Zealand’s consolidated trade environment is far more
advanced than many countries I’ve worked in. For example,
in France there are more than 20,000 pharmacies that we
would have to do separate trade interactions with. Here in
New Zealand, we work with key account distributors who are
professional, knowledgeable, understand categories and want
to collaborate to give the customer the best deal. You
simply don’t get that in many other
countries.”

Stuchly believes New Zealand is also more
liberal and generally open to new innovation, which makes
the registration process more efficient.

“That’s why
many companies tend to use New Zealand as a test market for
new innovative products. They can get them registered or
launched more easily, see how they go in the market and then
roll out to the rest of the world, not just OTC products,
but also beyond in other industries.

“People here really
do seem more open towards innovation, trying new products
and embracing new ideas, which is fantastic.”

Stuchly
says he is passionate about the concept of self-care and the
positive benefits it has on health care
systems.

“Self-care forms the foundation of health care
and is fast becoming the way that people manage their own
health – from choosing healthy lifestyles and using
non-prescription medicines effectively, to accessing proper
information and self-care learning tools to support
appropriate self-diagnosis and
self-treatment.

“Non-prescription drugs and other
self-care solutions uphold the sustainability of health care
systems. As such, self-care supports an aging population
that is more prosperous and better educated than previous
generations.”

Born and bred in Leverkusen Germany, the
location of Bayer’s global headquarters, Stuchly was born
with Bayer in his blood. His father worked for the company
as do many of his relatives, including aunties, cousins and
an uncle.

“Bayer has always been a part of my life and I
am delighted that it has brought me to New Zealand. I’ve
been welcomed wherever I go – there is a real friendliness
here and people are genuinely curious about where I come
from,” he says.

As for the future, Stuchly says he is
focused on continuing the steady growth of the Bayer New
Zealand Consumer Health business, which has two new product
launches before the end of the year.

He and his wife are
also looking forward to the imminent arrival of their second
child in early September – the first Kiwi born into the
Stuchly Bayer family.

ENDS

Bayer:
Science For A Better Life

Bayer is a global
enterprise with core competencies in the Life Science fields
of health care and agriculture. Its products and services
are designed to benefit people and improve their quality of
life. At the same time, the Group aims to create value
through innovation, growth and high earning power. Bayer is
committed to the principles of sustainable development and
to its social and ethical responsibilities as a corporate
citizen. In New Zealand, it supports numerous community and
environmental causes, including United Way New Zealand, the
Whangarei Native Bird Recovery Centre and the New Zealand
Innovation
Awards.

© Scoop Media

 

Leave a Reply

Your email address will not be published. Required fields are marked *

*

7 − four =